tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Recce Pharmaceuticals Announces Proposed Securities Issue to Strengthen Market Position
Company AnnouncementsRecce Pharmaceuticals Announces Proposed Securities Issue to Strengthen Market Position
13d ago
Recce Pharmaceuticals Secures A$30 Million Debt Facility to Advance Clinical Trials
PremiumCompany Announcements
Recce Pharmaceuticals Secures A$30 Million Debt Facility to Advance Clinical Trials
13d ago
FIL Limited Increases Stake in Recce Pharmaceuticals
PremiumCompany Announcements
FIL Limited Increases Stake in Recce Pharmaceuticals
18d ago
Recce Pharmaceuticals Announces Change in Substantial Shareholding
PremiumCompany Announcements
Recce Pharmaceuticals Announces Change in Substantial Shareholding
19d ago
Recce Pharmaceuticals Strengthens Financial Position with Share Issue and Loan Negotiations
PremiumCompany Announcements
Recce Pharmaceuticals Strengthens Financial Position with Share Issue and Loan Negotiations
19d ago
Recce Pharmaceuticals Expands Market Reach with New ASX Securities Quotation
PremiumCompany AnnouncementsRecce Pharmaceuticals Expands Market Reach with New ASX Securities Quotation
20d ago
Recce Pharmaceuticals Completes A$15.8 Million Capital Raising to Fund Phase 3 Trials
Premium
Company Announcements
Recce Pharmaceuticals Completes A$15.8 Million Capital Raising to Fund Phase 3 Trials
27d ago
Recce Pharmaceuticals Expands Patent Portfolio to China
Premium
Company Announcements
Recce Pharmaceuticals Expands Patent Portfolio to China
1M ago
FIL Limited Increases Stake in Recce Pharmaceuticals
PremiumCompany Announcements
FIL Limited Increases Stake in Recce Pharmaceuticals
1M ago
Recce Pharmaceuticals Director Increases Shareholding
PremiumCompany Announcements
Recce Pharmaceuticals Director Increases Shareholding
1M ago
Recce Pharmaceuticals Raises A$8.4 Million to Advance Phase 3 Trials
PremiumCompany Announcements
Recce Pharmaceuticals Raises A$8.4 Million to Advance Phase 3 Trials
1M ago
Recce Pharmaceuticals Announces Quotation of New Securities on ASX
PremiumCompany Announcements
Recce Pharmaceuticals Announces Quotation of New Securities on ASX
1M ago
Recce Pharmaceuticals Secures Canadian R&D Rebate
PremiumCompany AnnouncementsRecce Pharmaceuticals Secures Canadian R&D Rebate
2M ago
Recce Pharmaceuticals Updates Securities Issue Timeline
Premium
Company Announcements
Recce Pharmaceuticals Updates Securities Issue Timeline
2M ago
Recce Pharmaceuticals Extends Entitlement Offer Deadline
Premium
Company Announcements
Recce Pharmaceuticals Extends Entitlement Offer Deadline
2M ago
Recce Pharmaceuticals Partners with USAMRIID for Biodefense Pathogen Testing
PremiumCompany Announcements
Recce Pharmaceuticals Partners with USAMRIID for Biodefense Pathogen Testing
2M ago
Recce Pharmaceuticals Updates Investors on Clinical Progress and Funding
PremiumCompany Announcements
Recce Pharmaceuticals Updates Investors on Clinical Progress and Funding
2M ago
Recce Pharmaceuticals Announces $10.8 Million Entitlement Offer to Fund Clinical Trials
PremiumCompany Announcements
Recce Pharmaceuticals Announces $10.8 Million Entitlement Offer to Fund Clinical Trials
2M ago
Recce Pharmaceuticals Opens Entitlement Offer to Raise $10.8 Million
PremiumCompany Announcements
Recce Pharmaceuticals Opens Entitlement Offer to Raise $10.8 Million
2M ago
Recce Pharmaceuticals Expands Phase II Trial for Diabetic Foot Infections
PremiumCompany AnnouncementsRecce Pharmaceuticals Expands Phase II Trial for Diabetic Foot Infections
2M ago
Recce Pharmaceuticals Raises A$5 Million Through Share Placement
Premium
Company Announcements
Recce Pharmaceuticals Raises A$5 Million Through Share Placement
2M ago
Recce Pharmaceuticals Secures Funding for Advanced Clinical Trials
Premium
Company Announcements
Recce Pharmaceuticals Secures Funding for Advanced Clinical Trials
2M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >